Bin Lian1, Hong Li1, Yaobang Liu1, Dahai Chai1, Yali Gao2, Yangyang Zhang2, Jia Zhou2, Jinping Li3. 1. Department of Oncology Surgery, General Hospital of Ningxia Medical University, Yinchuan, 750004, Ningxia, China. 2. Ningxia Medical University, Yinchuan, 750004, Ningxia, China. 3. Department of Oncology Surgery, General Hospital of Ningxia Medical University, Yinchuan, 750004, Ningxia, China. m16521098620@163.com.
Abstract
BACKGROUND: Opioid binding protein/cell adhesion molecule-like (OPCML) has been demonstrated to be a tumor suppressor gene, as it has been shown in previous studies to play a tumor-suppressive role in a variety of cancers. However, the role of OPCML in breast tumorigenesis remains unclear. METHODS: In this study, we analyzed OPCML expression in breast cancers and adjacent non-tumor tissue samples and examined its molecular function in the breast cancer-derived cell lines MDA-MB-231 and MCF7. RESULTS: We found that OPCML was downregulated in most breast cancer samples but that this protein was expressed in most adjacent non-tumor samples. The loss or downregulation of OPCML is associated with hypermethylation of its promoter. Methylation of the OPCML promoter was detected in all breast cancer cell lines and primary tumors but was not detected in surgical margin tissues and normal breast tissues. Furthermore, functional assays showed that ectopic OPCML expression could inhibit breast tumor cell proliferation in vivo and in vitro and further suppresses tumor cell migration and invasion. CONCLUSION: Our results show that OPCML exerts its tumor-suppressive functions in human breast cancer cells. Moreover, the promoter-specific hypermethylation of OPCML plays an important role in human breast cancer development.
BACKGROUND:Opioid binding protein/cell adhesion molecule-like (OPCML) has been demonstrated to be a tumor suppressor gene, as it has been shown in previous studies to play a tumor-suppressive role in a variety of cancers. However, the role of OPCML in breast tumorigenesis remains unclear. METHODS: In this study, we analyzed OPCML expression in breast cancers and adjacent non-tumor tissue samples and examined its molecular function in the breast cancer-derived cell lines MDA-MB-231 and MCF7. RESULTS: We found that OPCML was downregulated in most breast cancer samples but that this protein was expressed in most adjacent non-tumor samples. The loss or downregulation of OPCML is associated with hypermethylation of its promoter. Methylation of the OPCML promoter was detected in all breast cancer cell lines and primary tumors but was not detected in surgical margin tissues and normal breast tissues. Furthermore, functional assays showed that ectopic OPCML expression could inhibit breast tumor cell proliferation in vivo and in vitro and further suppresses tumor cell migration and invasion. CONCLUSION: Our results show that OPCML exerts its tumor-suppressive functions in humanbreast cancer cells. Moreover, the promoter-specific hypermethylation of OPCML plays an important role in humanbreast cancer development.
Entities:
Keywords:
Breast cancer; Methylation; Migration; OPCML; Proliferation
Authors: J E Reed; J R Dunn; D G du Plessis; E J Shaw; P Reeves; A L Gee; P C Warnke; G C Sellar; D J Moss; C Walker Journal: Neuropathol Appl Neurobiol Date: 2007-02 Impact factor: 8.090
Authors: Cathy B Moelans; Petra van der Groep; Laurien D C Hoefnagel; Marc J van de Vijver; Pieter Wesseling; Jelle Wesseling; Elsken van der Wall; Paul J van Diest Journal: Cancer Lett Date: 2013-10-30 Impact factor: 8.679
Authors: Yan Cui; Ying Ying; Andrew van Hasselt; Ka Man Ng; Jun Yu; Qian Zhang; Jie Jin; Dingxie Liu; Johng S Rhim; Sun Young Rha; Myriam Loyo; Anthony T C Chan; Gopesh Srivastava; George S W Tsao; Grant C Sellar; Joseph J Y Sung; David Sidransky; Qian Tao Journal: PLoS One Date: 2008-08-20 Impact factor: 3.240